The report is titled ‘High-Throughput Screening Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the High-Throughput Screening market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market.
The global high-throughput screening market is expected to reach at a value of US$ 33.5 Ban by 2030 end at a CAGR of 7.6%.
Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/pressrelease/high-throughput-screening-market
High-Throughput Screening Introduction
High-throughput screening (HTS) can be perceived as a drug discovery procedure that enables automated testing of huge numbers of biological and/or chemical compounds for a particular biological target. In the pharmaceutical industry, high-throughput screening techniques are broadly utilized in handling automation and robotics to speedily test the biochemical or biological activity of a massive number of molecules, generally drugs. They boost target scrutiny, as wide scale compound archives can promptly be covered in an economical way.
High-throughput screening can also be perceived as a tool for examining as for example pharmacological targets, pharmacologically contouring agonists and antagonists for enzymes and receptors (such as GPCRs).
High-Throughput Screening Market Dynamics
The growing applications for the high-throughput screening techniques for the purpose of drug development as it cuts off the time taken to develop a drug is majorly driving its demand across the global markets. Owing to which, the global high throughput screening market is expected to witness substantial growth over the forthcoming years.
In addition to that, the surge in funding from the government for the acceptance and usage of innovative technologies such as CRISPR-Cas9 & RNAi, microplate-free approach, and machine learning & artificial intelligence also positively fuels the growth of the global high-throughput screening market.
However, inadequacy of skilled expertise and heavy capital investments in underdeveloped countries & developing countries are few factors that are likely to hinder the growth of the high-throughput screening market in the coming years.
High-Throughput Screening Market Segmentation
The global high-throughput screening market is segmented on the basis of product & service, technology, application, end user, and region.
By Product & Service
- Reagents & Assay Kits
- Laboratory Equipment
- Liquid Handling Systems
- Detection Systems
- Other Instruments
- Cell-based Assays
- 2D Cell Culture
- 3D Cell Culture
- Scaffold-based Technology
- Animal-derived Hydrogels
- Synthetic Hydrogels
- Inert Matrix/Solid Scaffolds
- Micropatterned Surfaces
- Scaffold-free Technology
- Ultra-low Binding Plates
- Hanging-drop Plates
- Other Scaffold-free Technologies
- Reporter-based Assays
- Perfusion Cell Culture
- Lab-on-a-Chip Technology (LOC)
- Label-free Technology
- Drug Discovery
- Biochemical Screening
- Life Sciences Research
- Other Applications
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Other End Users
- North America
- Latin America
- Asia Pacific
- Middle East
High-Throughput Screening Market Key Players
The key participating players of the global high-throughput screening market include Thermo Fisher Scientific Inc.
- Agilent Technologies,
- , Danaher Corporation,
- PerkinElmer, Inc.,
- Tecan Group Ltd.,
- AXXAM S.p.A.,
- Merck KGaA,
- Bio-Rad Laboratories, Inc.,
- Promega Corporation,
- Corning Incorporated, and Eurofins Scientific,
- among others.
About Reports and Insights:
Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
1820 Avenue M, Brooklyn
NY 11230, United States